# Extended Varenicline Treatment for Smoking Among Cancer Patients

> **NCT01756885** · PHASE3 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 207 (actual)

## Conditions studied

- Nicotine Dependence

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo
- **BEHAVIORAL:** Smoking Cessation Counseling

## Key facts

- **NCT ID:** NCT01756885
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2018-05-31
- **Final completion:** 2018-05-31
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2019-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01756885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01756885, "Extended Varenicline Treatment for Smoking Among Cancer Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01756885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*